While INR is a standard tool for monitoring anticoagulation with VKA, recent studies suggest that point of care INR testing may not reflect the real anticoagulation activity of VKA in APS, as interactions between antiphospholipid antibodies and thromboplastin reagent may occur. This evidence concerns the gene F3 and autoimmune polyendocrinopathy.